ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Short Interest Up 36.0% in December

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 52,121 shares, an increase of 36.0% from the November 30th total of 38,313 shares. Based on an average daily volume of 48,432 shares, the days-to-cover ratio is currently 1.1 days. Approximately 2.8% of the shares of the company are sold short. Approximately 2.8% of the shares of the company are sold short. Based on an average daily volume of 48,432 shares, the days-to-cover ratio is currently 1.1 days.

Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF

Several institutional investors have recently modified their holdings of SBIO. Strategic Financial Services Inc. increased its stake in ALPS Medical Breakthroughs ETF by 97.8% in the second quarter. Strategic Financial Services Inc. now owns 38,032 shares of the company’s stock valued at $1,144,000 after purchasing an additional 18,807 shares in the last quarter. Jones Financial Companies Lllp bought a new stake in shares of ALPS Medical Breakthroughs ETF in the 1st quarter valued at $782,000. Moran Wealth Management LLC raised its stake in ALPS Medical Breakthroughs ETF by 72.2% during the 3rd quarter. Moran Wealth Management LLC now owns 17,187 shares of the company’s stock worth $668,000 after buying an additional 7,206 shares during the period. Virtu Financial LLC bought a new position in ALPS Medical Breakthroughs ETF during the third quarter worth about $650,000. Finally, Sterling Investment Advisors Ltd. acquired a new position in ALPS Medical Breakthroughs ETF in the third quarter valued at about $315,000.

ALPS Medical Breakthroughs ETF Stock Down 1.0%

SBIO traded down $0.53 during trading on Tuesday, reaching $50.79. 36,537 shares of the company’s stock were exchanged, compared to its average volume of 21,525. ALPS Medical Breakthroughs ETF has a fifty-two week low of $22.33 and a fifty-two week high of $52.90. The business has a 50 day moving average price of $47.90 and a 200 day moving average price of $39.51.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.